Lemaitre Vascular (LMAT) Price to Sales (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Price to Sales for 17 consecutive years, with 31.17 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Sales rose 6.51% year-over-year to 31.17 in Q2 2026; TTM through Jun 2026 was 8.36, a 4.35% increase from a year earlier, with the FY2025 full-year figure at 7.4, down 21.7% from the prior year.
• Price to Sales was 31.17 for Q2 2026 at Lemaitre Vascular, down from 37.48 in the prior quarter.
• Over five years, Price to Sales peaked at 38.1 in Q3 2024 and troughed at 23.76 in Q2 2022.
• A 5-year average of 29.76 and a median of 28.96 in 2025 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales declined 26.9% in 2022 and jumped 48.92% in 2024, its largest moves.
• Over 5 years, Price to Sales stood at 24.83 in 2022, then increased by 4.45% to 25.94 in 2023, then jumped by 43.77% to 37.29 in 2024, then slipped by 23.16% to 28.65 in 2025, then grew by 8.79% to 31.17 in 2026.
• The last three Price to Sales figures came in at 31.17 (Q2 2026), 37.48 (Q1 2026), and 28.65 (Q4 2025), per Business Quant data.